218 related articles for article (PubMed ID: 9151781)
1. Rapamycin (sirolimus) inhibits proliferating cell nuclear antigen expression and blocks cell cycle in the G1 phase in human keratinocyte stem cells.
Javier AF; Bata-Csorgo Z; Ellis CN; Kang S; Voorhees JJ; Cooper KD
J Clin Invest; 1997 May; 99(9):2094-9. PubMed ID: 9151781
[TBL] [Abstract][Full Text] [Related]
2. Kinetics and regulation of human keratinocyte stem cell growth in short-term primary ex vivo culture. Cooperative growth factors from psoriatic lesional T lymphocytes stimulate proliferation among psoriatic uninvolved, but not normal, stem keratinocytes.
Bata-Csorgo Z; Hammerberg C; Voorhees JJ; Cooper KD
J Clin Invest; 1995 Jan; 95(1):317-27. PubMed ID: 7529261
[TBL] [Abstract][Full Text] [Related]
3. CDK4/cyclin D1/PCNA complexes during staurosporine-induced G1 arrest and G0 arrest of human fibroblasts.
Gadbois DM; Peterson S; Bradbury EM; Lehnert BE
Exp Cell Res; 1995 Sep; 220(1):220-5. PubMed ID: 7664838
[TBL] [Abstract][Full Text] [Related]
4. Rapamycin inhibits cdk4 activation, p 21(WAF1/CIP1) expression and G1-phase progression in transformed mouse fibroblasts.
Gaben AM; Saucier C; Bedin M; Barbu V; Mester J
Int J Cancer; 2004 Jan; 108(2):200-6. PubMed ID: 14639603
[TBL] [Abstract][Full Text] [Related]
5. Rapamycin blocks cell cycle progression of activated T cells prior to events characteristic of the middle to late G1 phase of the cycle.
Terada N; Lucas JJ; Szepesi A; Franklin RA; Domenico J; Gelfand EW
J Cell Physiol; 1993 Jan; 154(1):7-15. PubMed ID: 8419408
[TBL] [Abstract][Full Text] [Related]
6. Rapamycin inhibits ribosomal protein synthesis and induces G1 prolongation in mitogen-activated T lymphocytes.
Terada N; Takase K; Papst P; Nairn AC; Gelfand EW
J Immunol; 1995 Oct; 155(7):3418-26. PubMed ID: 7561036
[TBL] [Abstract][Full Text] [Related]
7. FKBP-rapamycin inhibits a cyclin-dependent kinase activity and a cyclin D1-Cdk association in early G1 of an osteosarcoma cell line.
Albers MW; Williams RT; Brown EJ; Tanaka A; Hall FL; Schreiber SL
J Biol Chem; 1993 Oct; 268(30):22825-9. PubMed ID: 8226793
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of D-type cyclins in HaCaT keratinocytes and in psoriasis.
Belsõ N; Széll M; Pivarcsi A; Kis K; Kormos B; Kenderessy AS; Dobozy A; Kemény L; Bata-Csörgõ Z
J Invest Dermatol; 2008 Mar; 128(3):634-42. PubMed ID: 17882269
[TBL] [Abstract][Full Text] [Related]
9. Increased LFA-1-mediated homotypic cell adhesion is associated with the G1 growth arrest induced by rapamycin in a T cell lymphoma.
Dumont FJ; Fischer P; Sirotina A
Exp Cell Res; 1995 Jul; 219(1):146-58. PubMed ID: 7543051
[TBL] [Abstract][Full Text] [Related]
10. G0/G1 arrest and S phase inhibition of human cancer cell lines by inositol hexaphosphate (IP6).
El-Sherbiny YM; Cox MC; Ismail ZA; Shamsuddin AM; Vucenik I
Anticancer Res; 2001; 21(4A):2393-403. PubMed ID: 11724298
[TBL] [Abstract][Full Text] [Related]
11. Rapamycin-FKBP inhibits cell cycle regulators of proliferation in vascular smooth muscle cells.
Marx SO; Jayaraman T; Go LO; Marks AR
Circ Res; 1995 Mar; 76(3):412-7. PubMed ID: 7532117
[TBL] [Abstract][Full Text] [Related]
12. IL-2-dependent induction of G1 cyclins in primary T cells is not blocked by rapamycin or cyclosporin A.
Turner JM
Int Immunol; 1993 Oct; 5(10):1199-209. PubMed ID: 8268127
[TBL] [Abstract][Full Text] [Related]
13. The RB/p107/p130 phosphorylation pathway is not inhibited in rapamycin-induced G1-prolongation of NIH3T3 cells.
Chen Y; Knudsen ES; Wang JY
Oncogene; 1996 Oct; 13(8):1765-71. PubMed ID: 8895523
[TBL] [Abstract][Full Text] [Related]
14. Rapamycin inhibits human renal epithelial cell proliferation: effect on cyclin D3 mRNA expression and stability.
Pallet N; Thervet E; Le Corre D; Knebelmann B; Nusbaum P; Tomkiewicz C; Meria P; Flinois JP; Beaune P; Legendre C; Anglicheau D
Kidney Int; 2005 Jun; 67(6):2422-33. PubMed ID: 15882288
[TBL] [Abstract][Full Text] [Related]
15. Rapamycin selectively blocks interleukin-2-induced proliferating cell nuclear antigen gene expression in T lymphocyte. Evidence for inhibition of CREB/ATF binding activities.
Feuerstein N; Huang D; Prystowsky MB
J Biol Chem; 1995 Apr; 270(16):9454-8. PubMed ID: 7721872
[TBL] [Abstract][Full Text] [Related]
16. Rapamycin inhibits p34cdc2 expression and arrests T lymphocyte proliferation at the G1/S transition.
Flanagan WM; Crabtree GR
Ann N Y Acad Sci; 1993 Nov; 696():31-7. PubMed ID: 8109837
[TBL] [Abstract][Full Text] [Related]
17. Flow cytometric identification of proliferative subpopulations within normal human epidermis and the localization of the primary hyperproliferative population in psoriasis.
Bata-Csorgo Z; Hammerberg C; Voorhees JJ; Cooper KD
J Exp Med; 1993 Oct; 178(4):1271-81. PubMed ID: 7690831
[TBL] [Abstract][Full Text] [Related]
18. FK506 and cyclosporin A inhibit growth factor-stimulated human keratinocyte proliferation by blocking cells in the G0/G1 phases of the cell cycle.
Karashima T; Hachisuka H; Sasai Y
J Dermatol Sci; 1996 Sep; 12(3):246-54. PubMed ID: 8884530
[TBL] [Abstract][Full Text] [Related]
19. Cell cycle progression out of G1 sensitizes primary-cultured nontransformed T cells to TCR-mediated apoptosis.
Radvanyi LG; Shi Y; Mills GB; Miller RG
Cell Immunol; 1996 Jun; 170(2):260-73. PubMed ID: 8660826
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-2-mediated elimination of the p27Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin.
Nourse J; Firpo E; Flanagan WM; Coats S; Polyak K; Lee MH; Massague J; Crabtree GR; Roberts JM
Nature; 1994 Dec; 372(6506):570-3. PubMed ID: 7990932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
